Crescentic glomerulonephritis induced by anti-vascular endothelial growth factor receptor 2 antibody

被引：0
|
作者：
Horino, Taro [1 ]
Inotani, Satoshi [1 ]
Ochi, Tsunehiro [2 ]
Ishihara, Masayuki [3 ]
Yagyu, Kenichi [4 ]
Ichii, Osamu [5 ]
Uchida, Kazushige [2 ]
Fujieda, Mikiya [3 ]
Terada, Yoshio [1 ]
机构：
[1] Kochi Univ, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi, Japan
[2] Kochi Univ, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan
[3] Kochi Univ, Dept Paediat, Nankoku, Kochi, Japan
[4] Kochi Univ, Kochi Med Sch, Sci Res Ctr, Nankoku, Kochi, Japan
[5] Hokkaido Univ, Fac Vet Med, Dept Basic Vet Sci, Lab Anat, Sapporo, Hokkaido, Japan
来源：
NEPHROLOGY | 2022年 / 27卷 / 04期
关键词：
D O I：
10.1111/nep.13969
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [21] Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model
    Sang Tae Choi
    Ji Hye Kim
    Jae-Yeon Seok
    Yong-Beom Park
    Soo-Kon Lee
    Clinical Rheumatology, 2009, 28 : 333 - 337
  • [22] Increased serum levels of vascular endothelial growth factor in human crescentic glomerulonephritis
    Nitta, K
    Uchida, K
    Kimata, N
    Honda, K
    Horita, S
    Hayashi, T
    Ishizuka, T
    Kobayashi, H
    Kawashima, A
    Yumura, V
    Nihei, H
    CLINICAL NEPHROLOGY, 1999, 52 (02) : 76 - 82
  • [23] Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma
    Terheyden, Patrick
    Hofmann, Maja Ann
    Weininger, M.
    Broecker, Eva-B.
    Becker, Juergen C.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (11) : 897 - 901
  • [24] Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model
    Choi, Sang Tae
    Kim, Ji Hye
    Seok, Jae-Yeon
    Park, Yong-Beom
    Lee, Soo-Kon
    CLINICAL RHEUMATOLOGY, 2009, 28 (03) : 333 - 337
  • [25] Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma
    Patrick Terheyden
    Maja Ann Hofmann
    M. Weininger
    Eva-B. Bröcker
    Jürgen C. Becker
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 897 - 901
  • [26] Addition of photodynamic therapy to anti-vascular endothelial growth factor drugs compared to anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy
    Manzur Yarur, Franco
    Meza V, Victor
    Garreton C, Rodolfo
    Munoz Q, Aldo
    MEDWAVE, 2021, 21 (08):
  • [27] Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis
    Rampino, T
    Gregorini, M
    Camussi, G
    Conaldi, PG
    Soccio, G
    Maggio, M
    Bottelli, A
    Dal Canton, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (06) : 1066 - 1074
  • [28] A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
    Yang, JC
    Haworth, L
    Sherry, RM
    Hwu, P
    Schwartzentruber, DJ
    Topalian, SL
    Steinberg, SM
    Chen, HX
    Rosenberg, SA
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05): : 427 - 434
  • [29] Anti-vascular endothelial growth factor for proliferative diabetic retinopathy
    Martinez-Zapata, Maria Jose
    Salvador, Ignacio
    Marti-Carvajal, Arturo J.
    Pijoan, Jose I.
    Cordero, Jose A.
    Ponomarev, Dmitry
    Kernohan, Ashleigh
    Sola, Ivan
    Virgili, Gianni
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):
  • [30] Ten years of anti-vascular endothelial growth factor therapy
    Napoleone Ferrara
    Anthony P. Adamis
    Nature Reviews Drug Discovery, 2016, 15 : 385 - 403
12345